Navigation Links
Quest Diagnostics to Speak at the 2008 Credit Suisse Healthcare Conference
Date:11/10/2008

MADISON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Credit Suisse Healthcare Conference on Wednesday, November 12, 2008. The Quest Diagnostics presentation is scheduled to begin at 10:00 a.m. Eastern Time.

During the conference, the company will reaffirm its 2008 guidance for revenue growth of greater than 8%, operating income to approach 17% of revenues, and adjusted earnings per diluted share from continuing operations of between $3.17 and $3.22. This excludes the impact of a third quarter equity investment write-down and hurricanes.

The presentation will be webcast live during the conference and will be available to registered investors on the following site: http://w.on24.com/r.htm?e=125462&s=1&k=FA4CC8E22828DA92BFF1D58C23AB47B1 and to the public on http://www.QuestDiagnostics.com/investor. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until December 14, 2008.

Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at: http://www.QuestDiagnostics.com.


'/>"/>
SOURCE Quest Diagnostics
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. NO on Prop 8 Responds to Debate Request From Frank Schubert
2. assisTek's ePRO Biotech Clinical Trial Data Collection Saves Client $1.6 Million Over Paper Questionnaires
3. Quest Diagnostics Reports Growth in Revenue and Earnings for Third Quarter 2008
4. Intimacy and Sexuality After Cancer: Questions Answered and Concerns Addressed
5. Questions Continue About Using Beta Blockers Before Surgery
6. Register by Oct. 21 for annual carbon sequestration meeting
7. Quest Diagnostics to Release Third Quarter 2008 Financial Results
8. Susan G. Komen for the Cure(R) Advocacy Alliance Suggests Questions for Vice Presidential Debate
9. Maryland Stem Cell Commission Issues Requests for Applications
10. New Questions Raised About Lung Cancer Screening
11. Will patients stick to physical therapy? Questionnaire can help doctors predict
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... On Tuesday, April 26, ... the Southeast, celebrated the signature of Gov. Nathan Deal on SB 258, the “Rural ... (R - Cumming), offers a 70% tax credit to individuals and corporations which donate ...
(Date:4/29/2016)... , ... April 29, 2016 , ... ... loans more flexibility in repaying their loans, more information about their loan terms ... when total outstanding student loan debt, including federal and private loans, has reached ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... that infants born with severe congenital diaphragmatic hernia have better survival rates if ... congenital diaphragmatic hernia (CDH)—a condition where the diaphragm fails to form completely, letting ...
(Date:4/29/2016)... ... 2016 , ... Mobility Designed is redefining mobility with their patent pending ... Crutch evenly distributes body weight from the elbow to the forearm. In consumer ... than with other crutches. , Co-founders Max and Liliana Younger were inspired to design ...
(Date:4/29/2016)... ... April 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about ... of skin cancer deaths. More than 10,000 people are expected to die of melanoma this ... it is the one of the most commonly diagnosed cancers in young women. A recent ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... MARLTON, N.J. , April 28, 2016   ... solutions, today announced that leading IT market research and ... Player " in the IDC MarketScape: Worldwide Pharmaceutical Track ... March 2016).  The report provides an assessment of the ... pharmaceutical track and trace software market. Logo ...
(Date:4/28/2016)... 28, 2016 New market ... is a report that provides an overview of ... pipelines by identifying new targets and MOAs to ... Profiles discussed in this H1 2016 Osteoarthritis Pipeline ... AbbVie Inc., Abiogen Pharma S.p.A., Ablynx NV, Achelios ...
(Date:4/27/2016)... Avril 2016   ... +5% sur le trimestre, soutenu par une croissance ... Croissance de +16% des ventes aux hôpitaux ... Kea Technologies (Euronext : MKEA, FR0010609263 ; OTCQX : MKEAY), inventeur ... aujourd,hui son chiffre d,affaires pour le premier trimestre ...
Breaking Medicine Technology: